VG

Vikas Goyal

Biotech company building, partnering, investing towards better medicines

Cambridge, Massachusetts

VC

Invests in

Stages:

Seed
Pre-seed

Sectors:

Locations:

  • Min Investment:

    $0.00

  • Max Investment:

    $0.00

  • Target Investment:

    $0.00

Skills

Venture Capital
Financial Modeling
Entrepreneurship
Biotechnology
Start-ups
Due Diligence
Business Development
Mergers
Strategic Planning
Corporate Development
Life Sciences
Lifesciences
Mergers & Acquisitions
Strategy
Valuation

Education

Investments

Pandion Therapeutics

Series A

Total Funding: $140M

Spero Therapeutics

Series A

Total Funding: $120M

Morphic Therapeutic

Series A

Total Funding: $140M

CalciMedica

Series A

Total Funding: $18M

Work Experience

Trekk Venture Partners

2022

  • Managing Partner and Co-Founder

    2022

    Trekk is a venture capital firm dedicated to investing in early stage biotech companies developing life-changing medicines.

Pandion therapeutics

2018 - 2021

  • Merck Integration

    2021 - 2021

  • SVP Business Development

    2019 - 2021

  • Board Member

    2018 - 2019

Morphic Therapeutic

2016 - 2021

  • Board Member

    2016 - 2021

Nimbus Therapeutics

2018 - 2019

  • Board Member

    2018 - 2019

Zikani Therapeutics

2015 - 2019

  • Board Member

    2015 - 2019

CalciMedica

2013 - 2019

  • Board Member

    2013 - 2019

SR One

2011 - 2019

  • Principal

    2011 - 2019

    Biotech venture capital for novel drug discovery and development companies in Boston and globally.

Spero Therapeutics

2014 - 2018

  • Board Member

    2014 - 2018

Infinity Pharmaceuticals

2010 - 2011

  • Manager, Corporate Strategy & Development

    2010 - 2011

SR One

2009 - 2010

  • Intern

    2009 - 2010